NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 117 filers reported holding NXSTAGE MEDICAL INC in Q2 2013. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $4,695,000 | +2.4% | 175,000 | 0.0% | 0.14% | -2.1% |
| Q4 2016 | $4,587,000 | +4.9% | 175,000 | 0.0% | 0.14% | +5.9% |
| Q3 2016 | $4,373,000 | +15.3% | 175,000 | 0.0% | 0.14% | +6.2% |
| Q2 2016 | $3,794,000 | +44.6% | 175,000 | 0.0% | 0.13% | +47.1% |
| Q1 2016 | $2,623,000 | +130.5% | 175,000 | +102.3% | 0.09% | +97.7% |
| Q3 2013 | $1,138,000 | -7.9% | 86,500 | 0.0% | 0.04% | -8.3% |
| Q2 2013 | $1,235,000 | – | 86,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |